Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
Launched by GALDERMA R&D · Nov 16, 2011
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female above 18 years;
- • 2. Subject with clinical diagnosis of mild AK on the face or the scalp with or without clinical diagnosis of moderate AK on the target areas (TAs);
- Exclusion Criteria:
- • 1. Subject with clinical diagnosis of at least one severe AK on TAs
- • 2. Subject with clinical diagnosis of other skin disease (including non-melanoma skin cancer) on the TAs;
- • 3. Subject with pigmented AK on the TAs
About Galderma R&D
Galderma R&D is a global leader in dermatological innovation, dedicated to advancing skin health through rigorous research and development. With a strong commitment to scientific excellence, Galderma focuses on creating effective and safe treatments for a variety of skin conditions, including acne, rosacea, and psoriasis. The organization collaborates with healthcare professionals and researchers worldwide to bring cutting-edge solutions to market, ensuring that patients receive the highest quality care. Through its extensive clinical trials and commitment to regulatory compliance, Galderma R&D strives to enhance the understanding of dermatological diseases and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phillip, Australian Capital Territory, Australia
Kogarah, New South Wales, Australia
Sydney, New South Wales, Australia
Westmead, New South Wales, Australia
Woolloongabba, Queensland, Australia
Carlton, Victoria, Australia
Patients applied
Trial Officials
Stephen Shumack
Principal Investigator
St George Dermatology and skin Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials